Clinical Trial Update: Simple Once Daily Triple Regimen Including Tenofovir, Emtricitabine and Efavirenz in HIV-1 Infected Patients (ANRS 1207) [Phase 3]

View source ↗

Summary

Phase 3 trial ANRS 1207 evaluated a once-daily fixed-dose triple regimen of tenofovir disoproxil fumarate, emtricitabine, and efavirenz in HIV-1 infection. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• EFAVIRENZ (efavirenz)
• Emtricitabine (Emtricitabine)
• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)

Snippet

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis | Conditions: HIV Infection | Phase 3 | Status: COMPLETED